Literature DB >> 11732705

Neuroimaging studies of the hippocampus in schizophrenia.

S Heckers1.   

Abstract

Three neuroimaging techniques, morphometric neuroimaging, magnetic resonance spectroscopy, and functional neuroimaging, have provided evidence for abnormal hippocampal structure and function in schizophrenia. Hippocampal volume reduction is now one of the most consistent structural abnormalities found in schizophrenia: it is present at the onset of the illness and, to a lesser degree, in first-degree relatives of schizophrenic probands. Decreased levels of N-acetyl-aspartate point towards a cellular basis of such volume changes. Functional neuroimaging studies have demonstrated abnormal levels of hippocampal activity at rest, during the experience of auditory hallucinations, and during the performance of memory retrieval tasks. These results of neuroimaging studies complement evidence from post-mortem and behavioral studies, which have found regionally specific abnormalities of the hippocampus and of memory function in schizophrenia.

Entities:  

Mesh:

Year:  2001        PMID: 11732705     DOI: 10.1002/hipo.1068

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  148 in total

Review 1.  The genetics of sensory gating deficits in schizophrenia.

Authors:  Robert Freedman; Ann Olincy; Randall G Ross; Merilyne C Waldo; Karen E Stevens; Lawrence E Adler; Sherry Leonard
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

Review 2.  Hippocampal neurons in schizophrenia.

Authors:  S Heckers; C Konradi
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

Review 3.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

Review 4.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

5.  NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus.

Authors:  Yuchun Zhang; Takashi Yoshida; Donald B Katz; John E Lisman
Journal:  J Neurophysiol       Date:  2012-03-14       Impact factor: 2.714

Review 6.  The treatment of cognitive impairment in schizophrenia.

Authors:  Donald C Goff; Michele Hill; Deanna Barch
Journal:  Pharmacol Biochem Behav       Date:  2010-11-27       Impact factor: 3.533

7.  Ketamine disrupts θ modulation of γ in a computer model of hippocampus.

Authors:  Samuel A Neymotin; Maciej T Lazarewicz; Mohamed Sherif; Diego Contreras; Leif H Finkel; William W Lytton
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

8.  Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia.

Authors:  Jason R Tregellas; Jason Smucny; Josette G Harris; Ann Olincy; Keeran Maharajh; Eugene Kronberg; Lindsay C Eichman; Emma Lyons; Robert Freedman
Journal:  Am J Psychiatry       Date:  2014-05       Impact factor: 18.112

9.  Hippocampal dysfunction during declarative memory encoding in schizophrenia and effects of genetic liability.

Authors:  Tara Pirnia; Roger P Woods; Liberty S Hamilton; Hannah Lyden; Shantanu H Joshi; Robert F Asarnow; Keith H Nuechterlein; Katherine L Narr
Journal:  Schizophr Res       Date:  2014-12-09       Impact factor: 4.939

Review 10.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.